We advised Enzyre on an investment by Novalis Biotechnology Incubation. Novalis, through its seed fund, participated as co-financer in the Corona Bridge Loan granted by the Dutch government in support of innovative start-ups and scale-ups. Enzyre develops breakthrough ambulant diagnostic technology focused on blood coagulation.